Ionis Pharmaceuticals, Inc. (IONS)
40.41
-0.83
(-2.01%)
USD |
NASDAQ |
Nov 03, 16:00
40.41
0.00 (0.00%)
After-Hours: 16:57
Ionis Pharmaceuticals Cash and Short Term Investments (Quarterly) : 2.055B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.055B |
| March 31, 2026 | 1.977B |
| December 31, 2025 | 2.677B |
| September 30, 2025 | 2.243B |
| June 30, 2025 | 2.293B |
| March 31, 2025 | 2.148B |
| December 31, 2024 | 2.303B |
| September 30, 2024 | 2.483B |
| June 30, 2024 | 2.079B |
| March 31, 2024 | 2.206B |
| December 31, 2023 | 2.338B |
| September 30, 2023 | 2.236B |
| June 30, 2023 | 2.385B |
| March 31, 2023 | 2.347B |
| December 31, 2022 | 1.997B |
| September 30, 2022 | 1.982B |
| June 30, 2022 | 2.022B |
| March 31, 2022 | 2.064B |
| December 31, 2021 | 2.131B |
| September 30, 2021 | 1.996B |
| June 30, 2021 | 2.063B |
| March 31, 2021 | 1.823B |
| December 31, 2020 | 1.899B |
| September 30, 2020 | 2.336B |
| June 30, 2020 | 2.351B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.389B |
| December 31, 2019 | 2.509B |
| September 30, 2019 | 2.223B |
| June 30, 2019 | 2.263B |
| March 31, 2019 | 2.255B |
| December 31, 2018 | 2.085B |
| September 30, 2018 | 1.959B |
| June 30, 2018 | 1.980B |
| March 31, 2018 | 1.035B |
| December 31, 2017 | 1.023B |
| September 30, 2017 | 1.011B |
| June 30, 2017 | 855.71M |
| March 31, 2017 | 860.28M |
| December 31, 2016 | 667.64M |
| September 30, 2016 | 697.23M |
| June 30, 2016 | 672.31M |
| March 31, 2016 | 723.51M |
| December 31, 2015 | 803.98M |
| September 30, 2015 | 830.79M |
| June 30, 2015 | 815.54M |
| March 31, 2015 | 788.50M |
| December 31, 2014 | 810.71M |
| September 30, 2014 | 640.43M |
| June 30, 2014 | 649.37M |
| March 31, 2014 | 694.88M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.587B |
| BridgeBio Pharma, Inc. | 1.539B |
| Biogen, Inc. | 1.304B |
| Ultragenyx Pharmaceutical, Inc. | 301.00M |
| Krystal Biotech, Inc. | -- |